Detalhe da pesquisa
1.
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum.
J Hepatol
; 73(3): 680-693, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353483
2.
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum.
Gastroenterology
; 159(2): 422-427.e1, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353369
3.
coreNASH: Multi-stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment.
Hepatol Commun
; 5(5): 774-785, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027268